Strasbourg, France

Evelyne Schaeffer


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Evelyne Schaeffer: Innovator in Anti-Infectious Compounds

Introduction

Evelyne Schaeffer is a notable inventor based in Strasbourg, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at preventing and treating infectious diseases. Her innovative work has led to the creation of a unique patent that showcases her expertise and dedication to improving healthcare.

Latest Patents

Evelyne Schaeffer holds a patent for "Mannosylated compounds useful for the prevention and the treatment of infectious diseases." This invention relates to new anti-infectious compounds consisting of a polar head with one to three mannose, dimannose, or trimannose moieties, which is coupled through an appropriate linker to a single lipid chain of at least 17 carbon atoms in length. The patent also includes pharmaceutical compositions and therapeutic uses of these compounds, highlighting their potential impact on public health.

Career Highlights

Throughout her career, Evelyne has worked with esteemed institutions such as the Université de Strasbourg and the Centre National de la Recherche Scientifique. Her involvement in these organizations has allowed her to collaborate with leading researchers and contribute to groundbreaking studies in her field.

Collaborations

Evelyne Schaeffer has collaborated with notable colleagues, including Rachid Baati and Laure Dehuyser. These partnerships have enriched her research and expanded the scope of her work in the pharmaceutical industry.

Conclusion

Evelyne Schaeffer's innovative contributions to the development of anti-infectious compounds demonstrate her commitment to advancing medical science. Her patent and collaborations reflect her significant role in the fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…